Clinical Trial Update: Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Clinical Trial Update reports Phase 3 results on the safety and efficacy of saxagliptin in triple therapy for subjects with type 2 diabetes. Results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Saxagliptin (saxagliptin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2016-03-17